# The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women

> **NCT03134157** · PHASE3 · UNKNOWN · sponsor: **Royan Institute** · enrollment: 60 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** oral drug and vaginal placebo
- **DRUG:** oral drug and oral placebo
- **DRUG:** Vaginal placebo+ oral placebo

## Key facts

- **NCT ID:** NCT03134157
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2021-06-14
- **Final completion:** 2021-09-14
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03134157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03134157, "The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03134157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*